News Daily News Potential Contributors to ESUS Explored in New Consensus Statement Todd Neale May 14, 2024
News Daily News Lp(a) Linked to Higher ASCVD Risks in Diverse Patient Groups Michael O'Riordan April 17, 2024
News Conference News ACC 2024 Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing Michael O'Riordan April 12, 2024
News Conference News ACC 2024 Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL Yael L. Maxwell April 09, 2024
News Conference News ACC 2024 Full AEGIS-II Results: Raising HDL With Apo A-I No Help After Acute MI Yael L. Maxwell April 06, 2024
News Conference News ACC 2024 Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT Todd Neale March 27, 2024
News Daily News High Lp(a) Levels Harmful in Patients With and Without ASCVD Michael O'Riordan February 27, 2024
News Daily News Niacin, When Broken Down by the Body, Can Spur Inflammation Caitlin E. Cox February 22, 2024
News Daily News Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level Yael L. Maxwell February 15, 2024
News Daily News AEGIS-II Misses Primary Endpoint, Dealing New Blow to HDL Hypothesis Todd Neale February 14, 2024
News Daily News Less Is More: Lp(a) Much More Atherogenic Than LDL Michael O'Riordan January 16, 2024
Presentation Complex Coronary Cases 2023 Lipoprotein(a): The New Kid on the Block Presenter: Pam R. Taub June 15, 2023